Arteriovenous Malformations Clinical Trial
Official title:
Validation of Core Biopsy of Vascular Anomalies for Clinical Pathology and Genomics
Verified date | April 2022 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this research is to gather information on the safety and effectiveness of core biopsy of vascular anomalies for clinical pathology and clinical genomics studies.
Status | Completed |
Enrollment | 3 |
Est. completion date | January 31, 2022 |
Est. primary completion date | January 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with a clinical and imaging diagnosis of a vascular anomaly. - No prior treatment for the vascular anomaly. - Subjects undergoing clinically indicated sclerotherapy, embolization and/or ablation. - Male or female with age greater than or equal to 18 years. - Capacity and willingness to provide a written informed consent.. Exclusion Criteria: - Subjects with prior treatment for their vascular anomaly. - Uncorrectable coagulopathy. - Pregnant and/or breast-feeding subjects. A negative pregnancy test within 48 hours of the procedure. |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic in Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adequacy of core biopsy of vascular anomalies for clinical genomics studies | DNA and RNA will be extracted from the biopsy specimens, undergo qualitative/quantitative quality control assessment and be analyzed by whole genome sequencing (DNA) and RNA sequence analysis (RNA-seq) to determine the adequacy of vascular anomaly biopsy for vascular anomaly genomics characterization. | 18 months | |
Primary | Adequacy of core biopsy of vascular anomalies for clinical pathology evaluation | Tissue from the vascular anomaly biopsies will undergo histopathology and immunohistochemical staining to determine the adequacy of vascular anomaly core biopsy for clinical pathology characterization. | 18 months | |
Secondary | Safety of vascular anomaly core biopsy | Number of participants with biopsy-related adverse events as assessed by CTCAE v4.0 | 30 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03306836 -
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2
|
N/A | |
Recruiting |
NCT03306823 -
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1
|
N/A | |
Completed |
NCT01347307 -
Stereotactic Body Radiotherapy for Spine Tumors
|
N/A | |
Recruiting |
NCT02042326 -
Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
|
Phase 2 | |
Recruiting |
NCT05484219 -
Functional Navigation in Surgery of Cerebral Tumors and Vascular Malformations
|
N/A | |
Recruiting |
NCT05484245 -
Sonography-guided Resection of Brain Mass Lesions
|
N/A | |
Recruiting |
NCT05477680 -
Intraoperative Brain Shift Calculation Study
|
N/A | |
Completed |
NCT03656211 -
Fertility After Diagnosis and Management of Acquired Uterine Arteriovenous Malformation
|
||
Completed |
NCT04246125 -
Patient Skin Dose in Interventional Radiology
|
||
Recruiting |
NCT02879071 -
Long Term Follow-up After Embolization of Brain Arteriovenous Malformations
|
||
Terminated |
NCT01801488 -
Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm
|
N/A | |
Recruiting |
NCT06259292 -
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
|
||
Recruiting |
NCT02098252 -
Treatment of Brain AVMs (TOBAS) Study
|
N/A | |
Completed |
NCT02378883 -
Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study
|
N/A | |
Completed |
NCT00783523 -
Influence of MMP on Brain AVM Hemorrhage
|
Phase 1 | |
Recruiting |
NCT05276934 -
Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI)
|
||
Recruiting |
NCT03031873 -
Evaluation of Susceptibility-weighted Magnetic Resonance Imaging and 4d-time-resolved Magnetic Resonance Angiography in Brain Arteriovenous Malformations
|
N/A | |
Withdrawn |
NCT02079818 -
Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System
|
Phase 4 | |
Completed |
NCT01381952 -
Image Quality and Radiation Dose in Angiography
|
N/A | |
Active, not recruiting |
NCT05418816 -
SelfWrap-Assisted Arteriovenous Fistulas
|
N/A |